A real-world study of the efficacy and safety of anti-programmed cell death-1 therapy combined with chemotherapy or targeted therapy in patients with advanced biliary tract cancer

BACKGROUND: Immune checkpoint inhibitors (ICIs) represent a breakthrough in cancer treatment. However, they have rarely been used to treat biliary tract cancer (BTC). In the current study, we aimed to evaluate and compare the efficacy and safety of anti-programmed cell death-1 (PD-1) therapy used al...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Gastrointest Oncol
Auteurs principaux: Sun, Danyang, Ma, Junxun, Wang, Jinliang, Wang, Lijie, Zhang, Sujie, Chen, Guangying, Li, Xiaoyan, Cui, Pengfei, Zheng, Xuan, Hu, Yi
Format: Artigo
Langue:Inglês
Publié: AME Publishing Company 2020
Sujets:
Original Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7807271/
https://ncbi.nlm.nih.gov/pubmed/33457011
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo-20-562
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires